Evidence map›Paper›PMID 24141640›Full record

ArticleDiabetologia2014

Differential white cell count and incident type 2 diabetes: the Insulin Resistance Atherosclerosis Study.

Carlos Lorenzo, Anthony J Hanley, Steven M Haffner

Open access · bronzeAbstract read
In one paragraph

Article in Diabetologia, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it, 72 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Diabetic Vasculopathy: Molecular Mechanisms and Clinical Insights.International journal of molecular sciences · 2024
    Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Carlos LorenzoDepartment of Medicine, University of Texas Health Science Center, 7703 Floyd Curl Drive, San Antonio, TX, 78229, USA, lorenzo@uthscsa.edu.
Anthony J Hanley
Steven M Haffner
The University of Texas Health Science Center at San Antonio · USUniversity of Toronto · CA

Funding

ZOLEDRONATE VS AREDIA IN MULTIPLE MYELOMA/BREAST CANCER W /BONE DISORDERSM01RR001346 · NCRR · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI WILLIAMSON, DOUGLAS E · 1985 to 2008
$23.1M
Institute for Integration of Medicine & Science: A Partnership to Improve HealthUL1TR001120 · NCATS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI CLARK, ROBERT A, HARGREAVES, KENNETH M · 2013 to 2017
$16.5M
Institute for Integration of Medicine & Science: A Partnership to Improve HealthKL2TR001118 · NCATS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI CLARK, ROBERT A, DOUGHERTY, DONALD M · 2013 to 2017
$3.4M
INSULIN RESISTANCE, HYPERGLYCEMIA AND ATHEROSCLEROSISU01HL047889 · NHLBI · KAISER FOUNDATION RESEARCH INSTITUTE · PI SELBY, JOE V · 1991 to 1999
–
INSULIN RESISTANCE AND ATHEROSCLEROSIS STUDY (IRAS)U01HL047890 · NHLBI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI BERGMAN, RICHARD N. · 1991 to 1999
–
INSULIN RESISTANCE AND CARDIOVASCULAR DISEASEU01HL047892 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI REWERS, MARIAN J. · 1991 to 1999
–
INSULIN RESISTANCE AND ATHEROSCLEROSIS STUDY (IRAS)U01HL047902 · NHLBI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI SAAD, MOHAMMED F · 1991 to 1999
–
INSULIN RESISTANCE AND ATHEROSCLEROSIS STUDY (IRAS)U01HL047887 · NHLBI · WAKE FOREST UNIVERSITY · PI WAGENKNECHT, LYNNE E · 1991 to 1999
–
NCATS NIH HHS KL2 TR001118NCATS NIH HHS UL1 TR001120NCRR NIH HHS M01 RR001346NCRR NIH HHS M01 RR01346NCRR NIH HHS M01 RR431NHLBI NIH HHS HL-47887NHLBI NIH HHS HL-47889NHLBI NIH HHS HL-47890NHLBI NIH HHS HL-47892NHLBI NIH HHS U01 HL047892NHLBI NIH HHS U01 HL047902
6 · The paper itself

Abstract

aims/hypothesisWhite cell count has been shown to predict incident type 2 diabetes, but differential white cell count has received scant attention. We examined the risk of developing diabetes associated with differential white cell count and neutrophil:lymphocyte ratio and the effect of insulin sensitivity and subclinical inflammation on white cell associations.

methodsIncident diabetes was ascertained in 866 participants aged 40-69 years in the Insulin Resistance Atherosclerosis Study after a 5 year follow-up period. The insulin sensitivity index (SI) was measured by the frequently sampled IVGTT.

resultsC-reactive protein was directly and independently associated with neutrophil (p < 0.001) and monocyte counts (p < 0.01) and neutrophil:lymphocyte ratio (p < 0.001), whereas SI was inversely and independently related to lymphocyte count (p < 0.05). There were 138 (15.9%) incident cases of diabetes. Demographically adjusted ORs for incident diabetes, comparing the top and bottom tertiles of white cell (1.80 [95% CI 1.10, 2.92]), neutrophil (1.67 [1.04, 2.71]) and lymphocyte counts (2.30 [1.41, 3.76]), were statistically significant. No association was demonstrated for monocyte count (1.18 [0.73, 1.90]) or neutrophil:lymphocyte ratio (0.89 [0.55, 1.45]). White cell and neutrophil associations were no longer significant after further adjusting for family history of diabetes, fasting glucose and smoking, but the OR comparing the top and bottom tertiles of lymphocyte count remained significant (1.96 [1.13, 3.37]). This last relationship was better explained by SI rather than C-reactive protein. CONCLUSIONS/

interpretationA lymphocyte association with incident diabetes, which was the strongest association among the major white cell types, was partially explained by insulin sensitivity rather than subclinical inflammation.

Indexed as

AdultAgedAtherosclerosisC-Reactive ProteinDiabetes Mellitus, Type 2FemaleHumansLeukocyte CountMaleMiddle AgedMonocytesNeutrophilsC-Reactive Protein

Identifiers

PMID24141640
PMCPMC3969879
OpenAlexW2053518007

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.